Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2008

01-07-2008 | Original Paper

Stimulant Injectors in Ukraine: The Next Wave of the Epidemic?

Authors: Robert E. Booth, Wayne E. K. Lehman, Carol F. Kwiatkowski, John T. Brewster, Larisa Sinitsyna, Sergey Dvoryak

Published in: AIDS and Behavior | Issue 4/2008

Login to get access

Abstract

This study was designed to assess differences in drug and sex-related risk behaviors between injectors of opiates only, opiate/sedative mix only and stimulants only. Participants were current out-of-treatment injection drug users (IDUs), unaware of their HIV status, recruited through street outreach in Kiev, Odessa and Makeevka/Donetsk, Ukraine. Overall, 22% tested positive for HIV, including 39% among opiate/sedative injectors, 19% among opiate injectors and 17% among stimulant injectors. Despite these differences, stimulant injectors were at higher risk than other IDUs in sharing a used needle/syringe, always injecting with others, injecting a drug solution drawn from a common container, having an IDU sex partner, not using condoms during vaginal or anal sex and on composite measures of injection and sex risks. After controlling for age differences, stimulant injectors remained at higher risk in their needle and sex risk behaviors. Without intervention, it is likely that HIV will increase among stimulant injectors.
Literature
Atlani, L., Carael, M., Brunet, J. B., Frasca, T., & Chaika, N. (2000). Social change and HIV in the former USSR: The making of a new epidemic. Social Science and Medicine, 50, 1547–1556.PubMedCrossRef
Ball, A., Rana, S., & Dehne, K. L. (1998). HIV prevention among injecting drug users: Responses in developing and transitional countries. Public Health Report, 113(Suppl. 1), 170–181.
Barnett, T., Whiteside, A., Khodakevich, L., Kruglov, Y., & Steshenko, V. (2000). The HIV/AIDS epidemic in Ukraine: Its potential social and economic impact. Social Science and Medicine, 51, 1387–1403.PubMedCrossRef
Boddiger, D. (2005). Methamphetamine use linked to rising HIV transmission. The Lancet, 365, 1217–1218.CrossRef
Booth, R. E., Kennedy, J., Brewster, T., & Semerik, O. (2003). Drug injectors and dealers in Odessa, Ukraine. Journal of Psychoactive Drugs, 35, 419–426.PubMed
Booth, R. E., Kwiatkowski, C. F., Brewster, J. T., Sinitsyna, L., & Dvoryak, S. (2006). Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS, 20, 2217–2223.PubMedCrossRef
Booth, R. E., Mikulich-Gilbertson, S. K., Brewster, J. T., Salomonson-Sautel, S., & Semerik, O. (2004). Predictors of self-reported HIV infection among drug injectors in Ukraine. Journal of the Acquired Immune Deficiency Syndromes, 35, 82–88.CrossRef
Booth, R. E., Crowley, T. J., & Zhang, Y. (1996). Substance abuse treatment entry, retention and effectiveness: Out-of-treatment opiate injection drug users. Drug and Alcohol Dependence, 42(1), 11–20.PubMedCrossRef
Carlson, R. G., Wang, J., Siegal, H. A., Falck, R. S., & Guo, J. (1994). An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Human Organization, 53, 279–286.
Centers for Disease Control and Prevention. (2005). Specific populations: How are they affected? HIV prevention in the third decade. Atlanta, Georgia.
Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A., & Moss, A. R. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA, 261(4), 561–565.PubMedCrossRef
Chintalova-Dallas, R., Lutzenko, D., Lazzarini, Z., & Case, P. (2006). Boltuska: Use of homemade amphetamine in Odessa, Ukraine. Second annual methamphetamine conference. Salt Lake City.
Coyle, S. (1993). The NIDA HIV counseling and education intervention model: Intervention manual (No. NIH Publication No. 93–3580). U.S. Department of Health and Human Services, GPO.
DeBell, D., & Carter, R. (2005). The impact of transition on public health in Ukraine: A case study of the HIV/AIDS epidemic. British Medical Journal, 331, 216–219.PubMedCrossRef
Dehne, K. L., Grund, J. C., Khodakevich, L., & Kobyshcha, Y. (1999). The HIV/AIDS epidemic among drug injectors in Eastern Europe: Patterns, trends and determinants. Journal of Drug Issues, 29, 729–776.
Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Andersen, M., Williams, M., Kotranski, L., Booth, R., Rhodes, F., Weatherby, N., Estrada, A. L., Fleming, D., Deren, S., & Tortu, S. (1994). Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383–392.
EuroHIV. (2005). HIV/AIDS surveillance in Europe: End-year report 2005. Saint-Maurice: Institute de Veille Sanitaire.
Guydish, J. R., Abramowitz, A., Woods, W., Black, D. M., & Sorenson, J. L. (1990). Changes in needle sharing among intravenous drug users: San Francisco 1986–88. American Journal of Public Health, 80, 995–997.PubMedCrossRef
Hamers, F. F., & Downs, A. M. (2003). HIV in Central and Eastern Europe. The Lancet, 361, 1035–1044.CrossRef
Hamers, F. F., Batter, V., Downs, A. M., Alix, J., Cazien, F., & Brunet, J. B. (1997). The HIV epidemic associated with injecting drug use in Europe: Geographic and time trends. AIDS, 11, 1365–1374.PubMedCrossRef
Hoffman, J.P., Su, S.S., & Pach, A. (1997) Changes in network characteristics and HIV risk behaviors among injection drug users. Drug and Alcohol Dependence, 46, 41–51.CrossRef
Khodakevich, L., & Dehne, K. L. (1998). HIV epidemics in drug-using populations and increasing drug use in Central and Eastern Europe. Global research network meeting on HIV prevention in drug-using populations. Geneva.
Kozlov, A. P., Shaboltas, A. V., Toussova, O. V., Verevochkin, S. V., Masse, B. R., & Perdue, T. (2002). HIV incidence and factors associated with HIV acquisition among injection drug users in St. Petersburg, Russia. AIDS, 20, 895–900.
Liitsolva K., Tashinova I., Laukkanen T., Korovina G., Smolskaja T., Momot O., Mashkilleyson N., Chaplinskas S., Brummer-Korvenkontio H., Vanhatalo J., Leninikki P., & Salminen, M.O. (1998). HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS, 12, 1907–1919.CrossRef
Maisto, S., McKay, J., & Conners, G. (1990). Self-reported issues in substance abuse: State of the art and future directions. Behavioral Assessment, 121, 117–134.
MAP Symposium on Eastern Europe. (1998). The determinants of the HIV/AIDS epidemics in Eastern Europe. Twelfth world AIDS conference. Geneva.
Ministry of Health Ukraine. (2006). HIV-infection in Ukraine: Information Bulletin No. 26. Kiev, Ukraine: Ukrainian AIDS Center, L.V. Gromashevskogo Institute of Epidemiology, Central Sanitary Epidemiological State if the Ministry of Health of Ukraine.
National Institute on Drug Abuse. (2002). Methamphetamine abuse and addiction. Research Report, NIH Publication No. 02–4210.
Pozynyak, V. B., Pelipas, V. E., Vievski, A. N., & Miroshnichenko, L. (2002). Illicit drug use and its health consequences in Belarus, Russian Federation and Ukraine: Impact of transition. European Addiction Research, 8, 184–189.CrossRef
Rhodes, T., Lowndes, C., Judd, A., Mikhailova, L. A., Sarang, A., Rylkov, A., Tichonov, M., Lewis, K., Ulyanova, N., Alpatova, T., Karavashkin, V., Khutorskoy, M., Hickman, M., Parry, J.V., & Renton, A. (2002). Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS, 16(13), F25–F31.PubMedCrossRef
Rhodes, T., Sarang, A., Bobrik, A., Bobkov, E., & Platt, L. (2004). HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. International Journal of Drug Policy, 15, 1–16.CrossRef
Rhodes, T., Stimson, G. V., Crofts, N., Ball, A., Dehne, K., & Khodakevich, L. (1999). Drug injecting, rapid HIV spread, and the ‘risk environment’: Implications for assessment and response. AIDS, 13(Suppl. A), S259–S269.PubMed
Scherbinska, A. (2006). HIV infection in Ukraine: A review of epidemiological data. XVI International AIDS Conference. Vancouver.
Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., Feiner, C., & Friedland, G. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine, 321(13), 874–879.PubMedCrossRef
Somlai, A. M., Kelly, J. A., Benotsch, E., Gore-Felton, C., Ostrovski, D., McAuliffe, T., & Kozlov, A.P. (2002). Characteristics and predictors of HIV risk behaviors among injection-drug using men and women in St. Petersburg Russia. AIDS Education and Prevention, 14, 295–305.PubMedCrossRef
Twitchell, G. R., Huber, A., Reback, C. J., & Shoptaw, S. (2002). Comparison of general and detailed HIV risk assessments among methamphetamine abusers. AIDS and Behavior, 6(2), 153–162.CrossRef
Ukraine Center for AIDS Prevention and Ministry for Health of Ukriane/UNAIDS. (1999). Ukraine and the AIDS Epidemic. Kiev: UNAIDS.
UNAIDS/WHO and Joint United Nations Program on HIV/AIDS. (2002). AIDS epidemic update 2002. Geneva, Switzerland: UNAIDS and WHO.
UNAIDS/WHO. (2006). Progress in scaling up access to HIV treatment in low- and middle income countries, June 2006. Fact Sheet. Geneva: UNAIDS and WHO.
UNDP. (1999). Human Development Report 1999. New York: Oxford University Press.
UNICEF. (1999). After the fall: The human impact of ten years if transition. The Monee Project CSS/CIS. Florence: UNICEF, International Child Development Centre.
UNIDCP. (1997). United Nations International Drug Control Program: World Drug Report. New York: Oxford University Press.
United Nations. (1997). Economic Commission for Europe, Trends in Europe and North America 1996/1997. Geneva: The Statistical Yearbook.
USAID. (2002). HIV/AIDS in Ukraine: A USAID Brief. Washington, DC: TvT Associates—The Synergy Project.
Walker, N., Garcia-Calleja, J. M., Heaton, L., Asamoah-Odei, E., Poumerol, G., Lazzari, S. Ghys, P. D., Schwartlander, B., & Stanecki, K. A. (2001). Epidemiological analysis of the quality of HIV sero-surveillance in the world: How well do we track the epidemic? AIDS, 15, 1545–1554.
Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., Williams, M., & Chitwood, D. D. (1994). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17(4), 347–355.CrossRef
WHO. (1995). The current global situation of the HIV/AIDS pandemic. Weekly Epidemiological Record, 70, 355 (Geneva).
Wiebel, W. W. (1988). Combining ethnographic and epidemiological methods in targeted AIDS interventions: The Chicago model. In R. J. Battjes & R. W. Pickens (Eds.), Needle sharing among intravenous drug users: National and international perspectives (pp. 137–150). Washington, DC: U.S. Government Printing Office, National Institute on Drug Abuse Monograph No. 80.
Wiebel, W., Ouellet, L., Guydan, C., & Samairat, N. (1990) Cocaine injection as a predictor of HIV risk behaviors. XI International Conference on AIDS. Vancouver.
Metadata
Title
Stimulant Injectors in Ukraine: The Next Wave of the Epidemic?
Authors
Robert E. Booth
Wayne E. K. Lehman
Carol F. Kwiatkowski
John T. Brewster
Larisa Sinitsyna
Sergey Dvoryak
Publication date
01-07-2008
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2008
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-008-9359-3

Other articles of this Issue 4/2008

AIDS and Behavior 4/2008 Go to the issue

Substantive Review

Effects of HIV-Prevention Interventions for Samples with Higher and Lower Percents of Latinos and Latin Americans: A Meta-Analysis of Change in Condom Use and Knowledge

Erratum

The Relationship Between Alcohol Consumption and Unprotected Sex Among Known HIV-discordant Couples in Rwanda and Zambia

Original Paper

Popular Use of Traditional Chinese Medicine in HIV Patients in the HAART era

Original Paper

New Populations at High Risk of HIV/STIs in Low-income, Urban Coastal Peru

Original Paper

Sexual Difficulties in People Living with HIV in France—Results from a Large Representative Sample of Outpatients Attending French Hospitals (ANRS-EN12-VESPA)

Original Paper

The Relationship Between Alcohol Consumption and Unprotected Sex Among Known HIV-discordant Couples in Rwanda and Zambia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits